POSTMENOPAUSAL OSTEOPOROSIS
Clinical trials for POSTMENOPAUSAL OSTEOPOROSIS explained in plain language.
Never miss a new study
Get alerted when new POSTMENOPAUSAL OSTEOPOROSIS trials appear
Sign up with your email to follow new studies for POSTMENOPAUSAL OSTEOPOROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study tests alternative to prevent bone loss after stopping popular osteoporosis drug
Disease control Not yet recruitingThis study aims to find out if a drug called ibandronate works as well as the current standard drug, zoledronic acid, to protect bones after women stop taking denosumab for osteoporosis. It will involve 52 postmenopausal women who have taken denosumab for less than three years. R…
Matched conditions: POSTMENOPAUSAL OSTEOPOROSIS
Phase: PHASE4 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Skin scan may reveal why bone drugs fail for some
Disease control Not yet recruitingThis study aims to understand why some people with osteoporosis continue to break bones even while taking bone-strengthening medication. Researchers will use a quick, non-invasive skin scan to measure 'AGEs,' natural waste products that build up over time and may weaken bone qual…
Matched conditions: POSTMENOPAUSAL OSTEOPOROSIS
Sponsor: Bursa City Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Can a berry pill slow bone loss? new Gut-Bone study seeks answers
Disease control Not yet recruitingThis study aims to see if taking a blackcurrant supplement for a year can help slow bone loss in women after menopause. Researchers will measure changes in bone density and gut bacteria in about 160 participants. The goal is to understand if this natural approach could become a f…
Matched conditions: POSTMENOPAUSAL OSTEOPOROSIS
Phase: PHASE1 • Sponsor: University of Connecticut • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC